Marshall Wace, LLP Taro Pharmaceutical Industries LTD Transaction History

Marshall Wace, LLP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$40.97 - $43.33 $307,275 - $324,975	7,500 New	7,500 $317,000
Q4 2022 Feb 14, 2023	SELL	$27.6 - $32.99 $23,046 - $27,546	-835 Reduced 9.09%	8,348 $242,000
Q3 2022 Nov 14, 2022	SELL	$28.74 - $39.9 $33,855 - $47,002	-1,178 Reduced 11.37%	9,183 $275,000
Q2 2022 Aug 15, 2022	BUY	$35.0 - $43.59 $362,635 - $451,635	10,361 New	10,361 $374,000
Q2 2020 Aug 13, 2020	SELL	$61.66 - $70.16 $568,751 - $647,155	-9,224 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$59.35 - $88.73 $547,444 - $818,445	9,224 New	9,224 $565,000
Q4 2019 Feb 14, 2020	SELL	$74.18 - $97.92 $2.93 Million - $3.86 Million	-39,432 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$75.36 - $86.57 $2.37 Million - $2.72 Million	31,418 Added 392.04%	39,432 $2.98 Million
Q2 2019 Aug 14, 2019	BUY	$83.92 - $108.88 $672,534 - $872,564	8,014 New	8,014 $685,000
Q4 2018 Feb 14, 2019	SELL	$78.25 - $107.92 $548,297 - $756,195	-7,007 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$97.82 - $116.09 $685,424 - $813,442	7,007 New	7,007 $689,000

694K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.